Abstract
Multivisceral transplantation has brought new opportunities in the treatment of organ failure, offering better outcomes and quality of life to patients. Standardized surgical technique was developed in 1997. Currently, living donor (LD) intestinal transplant has been perfected relative to technical details, leading results comparable with those performed with deceased donors (DDs). Additional advantages such as elimination of waiting time, better human leukocyte antigen (HLA) matching, short ischemia time, and being scheduled as an elective surgery are achieved with this type of procedure. Regenerative medicine constitutes a pathway of innovate techniques in the treatment of intestinal failure; however, further research needs to be performed to fully translate regenerative medicine into the clinical field.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
